Effect of erythropoietin on athletic performance: a systematic review and meta-analysis
Authors:
Open Access
- 28 April 2020
- journal article
- review article
- Published by BMJ in BMJ Open Sport & Exercise Medicine
- Vol. 6 (1) , e000716
Abstract
Introduction Athletes have attempted to glean the ergogenic benefits of recombinant human erythropoietin (rHuEPO) since it became available in the 1980s. However, there is limited consensus in the literature regarding its true performance-enhancing effects. In fact, some studies suggest there is no conclusive evidence; therefore, it is necessary to evaluate and quantify the strength of the evidence. Objective To determine the effects of erythropoietin on enhancing athletic performance. Design At least two independent reviewers conducted citation identification through abstract and full-text screening, and study selection, and extracted raw data on demographics, descriptions of interventions and all outcomes to predesigned abstraction forms. Outcomes were stratified by treatment periods and dosages. Study quality was assessed using the Cochrane Risk of Bias Tool and Cochrane Grading of Recommendations Assessment Development and Education (GRADE) scale. Where appropriate, quantitative analysis was performed. Data sources EMBASE, MEDLINE and SPORTDiscus were searched from their inception to January 2020. Eligibility criteria Trials that examined any enhancement in sport in healthy participants aged 18–65 using rHuEPO compared with placebo were included. Results Overall, there is low-to-moderate quality evidence suggesting rHuEPO may be more beneficial than placebo in enhancing haematological parameters, pulmonary measures, maximal power output and time to exhaustion independent of dosage. However, these improvements are almost exclusively seen during maximal exercise intensities, which may be less relevant to athletic competition conditions. Conclusion Due to heterogeneity among trials, more high-quality randomised controlled trials with larger sample sizes in conditions that mirror actual competition are needed to further elucidate these effects.Keywords
This publication has 27 references indexed in Scilit:
- Effects of erythropoietin administration on cerebral metabolism and exercise capacity in menJournal of Applied Physiology, 2010
- Impact of Alterations in Total Hemoglobin Mass on V˙O2maxExercise and Sport Sciences Reviews, 2010
- Testing for maximum oxygen consumption has produced a brainless mode of human exercise performanceBritish Journal of Sports Medicine, 2008
- Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volumeThe Journal of Physiology, 2006
- Erythropoietin and blood dopingBritish Journal of Sports Medicine, 2006
- Effects of recombinant human erythropoietin injections on physical self in endurance athletesJournal of Sports Sciences, 2006
- Differentiating Factors Between Erythropoiesis-Stimulating AgentsDrugs, 2004
- Faster oxygen uptake kinetics at the onset of submaximal cycling exercise following 4 weeks recombinant human erythropoietin (r-HuEPO) treatmentPflügers Archiv - European Journal of Physiology, 2003
- Modelling the Transfers of Training Effects on Performance in Elite TriathletesInternational Journal of Sports Medicine, 2001
- Effect of rhEPO administration on serum levels of sTfR and cycling performanceMedicine & Science in Sports & Exercise, 2000